Sealantium Overview

  • Founded
  • 2011

Founded
  • Status
  • Private

  • Employees
  • 6

Employees
  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $10M

  • Investors
  • 4

Sealantium General Information

Description

Manufacturer of bi-component hemostatic and sealing products designed to control severe bleeding and seal leakages during and post-surgery. The company's products consist of a polymeric film with a biological sealant and include fibrin sealant, enabling doctors to control hemorrhages in cases of first aid, trauma care, and surgery.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Surgical Devices
Primary Office
  • Amal 11 Street
  • Rosh Haayin 4809239
  • Israel

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sealantium Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series B) 15-Oct-2018 $10M 000.00 Completed Generating Revenue
3. Grant 28-Nov-2017 00.000 00.000 Completed Generating Revenue
2. Later Stage VC 25-Jan-2017 $1.25M $1.25M 00.000 Completed Generating Revenue
1. Accelerator/Incubator Completed Startup
To view Sealantium’s complete valuation and funding history, request access »

Sealantium Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Preferred A1 00,000 00.000000 000.00 000.00 00 000.00 00.000
To view Sealantium’s complete cap table history, request access »

Sealantium Patents

Sealantium Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3769068-A1 Method for determining the adhesive force of a hemostatic tissue sealant patch Pending 22-Mar-2018 000000000
JP-2021518248-A How to measure the adhesive strength of a hemostatic sealant patch Pending 22-Mar-2018 000000000
CA-3094759-A1 Method for determining the adhesive force of a hemostatic tissue sealant patch Pending 22-Mar-2018 000000000
GB-2586544-A Method for determining the adhesive force of a hemostatic tissue sealant patch Pending 22-Mar-2018 000000000 0
AU-2019240359-A1 Method for determining the adhesive force of a hemostatic tissue sealant patch Pending 22-Mar-2018 G01N19/04
To view Sealantium’s complete patent history, request access »

Sealantium Executive Team (2)

Name Title Board Seat Contact Info
Orgad Laub Founder & Chief Executive Officer
Yonatan Naveh Vice President of Finance
To view Sealantium’s complete executive team members history, request access »

Sealantium Board Members (2)

Name Representing Role Since
Chris Lamb Self Board Member 000 0000
Michael Barnes Self Board Member 000 0000
To view Sealantium’s complete board members history, request access »

Sealantium Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sealantium Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Avv Investment Venture Capital Minority 000 0000 000000 0
Horizon 2020 SME Instrument Government 000 0000 000000 0
Everett Partners Venture Capital Minority 000 0000 000000 0
Targetech Innovation Center Accelerator/Incubator Minority 000 0000 000000 0
To view Sealantium’s complete investors history, request access »